Helix BioPharma (FRA:HBP0) Shares Buyback Ratio % : -13.12 (As of Dec. 15, 2024)

View and export this data going back to . Start your Free Trial

What is Helix BioPharma Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Helix BioPharma's current shares buyback ratio was -13.12%.

Helix BioPharma Shares Buyback Ratio % Historical Data

The historical data trend for Helix BioPharma's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Helix BioPharma Shares Buyback Ratio % Chart

Helix BioPharma Annual Data

Trend

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Jul24

Shares Buyback Ratio %

Get a 7-Day Free Trial

-19.52

-6.17

-21.73

-26.12

-13.12

Helix BioPharma Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Shares Buyback Ratio %	Get a 7-Day Free Trial															-8.33	-	-	-5.89	-6.83

Helix BioPharma Shares Buyback Ratio % Calculation

Helix BioPharma's Shares Buyback Ratio for the fiscal year that ended in Jul. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Jul. 2023 )	-	Shares Outstanding (EOP) (A: Jul. 2024 ))	/	Shares Outstanding (EOP) (A: Jul. 2023 )
	=	(43.3349	-	49.0215)	/	43.3349
	=	-13.12%

Helix BioPharma's Shares Buyback Ratio for the quarter that ended in Jul. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Apr. 2024 )	-	Shares Outstanding (EOP) (A: Jul. 2024 ))	/	Shares Outstanding (EOP) (A: Apr. 2024 )
	=	(45.8882	-	49.0215)	/	45.8882
	=	-6.83%

Helix BioPharma Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Helix BioPharma's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Helix BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helix BioPharma Corp (FRA:HBP0) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

HBPCF:USA HBP:Canada

Address

40 Temperance Street, Suite 2700, Bay Adelaide Centre - North Tower, Toronto, ON, CAN, M5H0B4

Website

https://www.helixbiopharma.com

Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidate is L-DOS47 for Tumor Defence Breaker is in clinical trials for pancreatic cancer.

Helix BioPharma Headlines

No Headlines